Logic suggests that it has to be Private Portfolio Partners or Ausbil.
They each held 22-23m shares but the holdings are both under 5% and so they will not be making any announcements about changes to substantial shareholdings.
The bigger questions are why are they selling, what do they know, do they have any informal information that is not known in the market.
The company can't announce anything as they do not know anything as they are like us dependent upon the independent clinical trial company providing the results.
I would expect BNO to go into a trading halt once the company gets the report in order to give themselves time to read and assess the results and prepare a detailed ASX release.
Latest BNO announcement say that it will have results out late September 2018.
I note that they have still not advised the market about progress on oncology asset sales -which is not a good sign either.
These assets were put on the chopping block nearly 10 months or more ago.
Don't start me on how much cash they have burned through...........
BNO Price at posting:
46.0¢ Sentiment: Hold Disclosure: Held
